Related Experiment Video
Updated: Apr 26, 2026
07:43
Modeling Charcot-Marie-Tooth Disease In Vitro by Transfecting Mouse Primary Motoneurons
Published on: January 7, 2019
6.4K
Amyotrophic lateral sclerosis: a proposed mechanism
Ayako Okado-Matsumoto1, Irwin Fridovich
1Department of Biochemistry, Duke University Medical Center, Durham, NC 27710, USA.
Summary
Heat shock proteins (Hsps) prevent mutant copper-zinc-superoxide dismutase (SOD1) from entering mitochondria, a process crucial for motor neuron survival in familial amyotrophic lateral sclerosis (FALS). This interaction sequesters Hsps, contributing to motor neuron death.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Missense mutations in copper-zinc-superoxide dismutase (SOD1) cause ~20% of familial amyotrophic lateral sclerosis (FALS).
- Mitochondrial dysfunction, including swelling and vacuolization, is an early indicator of motor neuron degeneration in FALS.
- SOD1 has been previously localized to the mitochondrial intermembrane space.
Purpose of the Study:
- To investigate the mechanism of SOD1 entry into mitochondria.
- To determine the role of heat shock proteins (Hsps) in the mitochondrial uptake of mutant SOD1.
- To elucidate the potential contribution of Hsp-mutant SOD1 interactions to FALS pathogenesis.
Main Methods:
- Demetallation assays to assess SOD1 mitochondrial entry.
- In vitro experiments using neuroblastoma cell extracts to study Hsp-SOD1 interactions.
- Analysis of aggregate formation in the presence of wild-type and mutant SOD1 with Hsps.
Main Results:
- SOD1 entry into mitochondria is dependent on its demetallation.
- Heat shock proteins (Hsp70, Hsp27, Hsp25) specifically inhibit the mitochondrial uptake of FALS-associated mutant SOD1 (G37R, G41D, G93A), but not wild-type SOD1.
- Binding of mutant SOD1 to Hsps in cell extracts promotes the formation of sedimentable aggregates, potentially sequestering Hsps from their antiapoptotic roles.
Conclusions:
- The interaction between Hsps and mutant SOD1 may impair the antiapoptotic functions of Hsps, contributing to motor neuron death in FALS.
- The Hsp-mutant SOD1 complex appears to recruit other cellular proteins, leading to aggregate formation within motor neurons.
- Understanding these interactions provides insights into the toxic gain-of-function mechanism in FALS.
Related Concept Videos
01:26Cross-bridge Cycle
108.6K
As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
108.6K
03:03Amyloid Fibrils
10.1K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
10.1K
01:15Parkinson's Disease: Overview
2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K
01:24Parkinson Disease l: Introduction
17
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of...
17
01:24Parkinson Disease ll: Pathophysiology
16
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
16
01:22Myasthenia Gravis ll: Pathophysiology
41
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
41